The interactions between attention deficit hyperactivity syndrome and addictions

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

In the article, a group of early career psychiatrists presents the results of a discussion about the relationship between attention deficit and hyperactivity disorder (ADHD) and addictions. Modern views on the commonality of the occurrence of these conditions at the genetic, morphological and functional levels are considered. Possible clinical manifestations and the frequency of comorbidity are described. Modern pharmacological and non-pharmacological approaches to the treatment of these comorbid conditions are discussed in detail separately. The features of therapy in the combination of ADHD with various addictions are highlighted.

About the authors

Tanay Maiti

Jagannath Gupta Institute of Medical Sciences

Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0001-8880-8773

MD, DPM, DNB, MNAMS, Assistant Professor

India, Kolkata

Samiksha Sahu

Topiwala Medical College & BYL Nair CH Hospital

Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0001-5867-9624

MD, Fellow, Child and Adolescent Mental Health, Department of Psychiatry

India, Mumbai

Laura Orsolini

Polytechnic University of Marche

Email: drtanaymaiti@gmail.com
ORCID iD: 0000-0002-6882-3770

MB ChB (Hons), MD, Dr.Sci.(Med.), MScCrim, PGCert (Forensic PSY), Psychiatrist and Clinical Researcher at Unit of Clinical Psychiatry, Department of Clinical Neurosciences / DIMSC, School of Medicine

Italy, Ancona

Ganesh Shanker

GSVM Medical College

Email: drtanaymaiti@gmail.com

MD, DCH, FIPS, Assistant Professor, Department of Psychiatry

India, Kanpur

Il'ya A. Fedotov

Reazan State Medical University

Author for correspondence.
Email: ilyafdtv@rambler.ru
ORCID iD: 0000-0002-2791-7180
SPIN-code: 4004-4132

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Ryazan

References

  1. Barkley RA, Fischer M, Smallish L, et al. Young adult follow-up of hyperactive children: antisocial activities and drug use. Journal of Child Psychology and Psychiatry, and Allied Disciplines. 2004;45(2):195–211. doi: 10.1111/j.1469-7610.2004.00214.x
  2. Sibley MH, Pelham WE, Molina BSG, et al. The role of early childhood ADHD and subsequent CD in the initiation and escalation of adolescent cigarette, alcohol, and marijuana use. Journal of Abnormal Psychology. 2014;123(2):362–74. doi: 10.1037/a0036585
  3. Charach A, Yeung E, Climans T, et al. Childhood Attention-Deficit/Hyperactivity Disorder and Future Substance Use Disorders: Comparative Meta-Analyses. Journal of the American Academy of Child and Adolescent Psychiatry. 2011;50(1):9–21. doi: 10.1016/j.jaac.2010.09.019
  4. van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug and Alcohol Dependence. 2012;122(1-2):11–9. doi: 10.1016/j.drugalcdep.2011.12.007
  5. Evren C, Evren B, Bozkurt M, et al. Effects of lifetime tobacco, alcohol and drug use on psychological and behavioral problems among 10th grade students in Istanbul. International Journal of Adolescence Medicine and Health. 2015;27(4):405–13. doi: 10.1515/ijamh-2014-0040
  6. Darke S, De Genhardt L, Mattick R. Mortality Amongst Illicit Drug Users: Epidemiology, Causes, and Intervention. Cambridge: Cambridge University Press; 2006.
  7. Slobodin O, Crunelle CL. Mini Review: Socio-Cultural Influences on the Link Between ADHD and SUD. Frontiers in Public Health. 2019;7:173. doi: 10.3389/fpubh.2019.00173
  8. Polanczyk G, de Lima M, Horta B, et al. The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis. American Journal of Psychiatry. 2007;164(6):942–8. doi: 10.1176/ajp.2007.164.6.942
  9. Hayman V, Fernandez TV. Genetic Insights Into ADHD Biology. Frontiers in Psychiatry. 2018;9:251. doi: 10.3389/fpsyt.2018.00251
  10. Robles R, de la Peña F, Medina-Mora M, et al. ICD-11 Guidelines for Mental and Behavioral Disorders of Children and Adolescents: Reliability and Clinical Utility. Psychiatric Services. 2021:appi.ps.2020008. doi: 10.1176/appi.ps.202000830
  11. Perugi G, Pallucchini A, Rizzato S, et al. Pharmacotherapeutic strategies for the treatment of attention-deficit hyperactivity (ADHD) disorder with comorbid substance-use disorder (SUD). Expert Opinion of Pharmacotherapy. 2018;20(3):343–55. doi: 10.1080/14656566.2018.1551878
  12. Posner J, Polanczyk G, Sonuga-Barke E. Attention-deficit hyperactivity disorder. The Lancet. 2020;395(10222):450–62. doi: 10.1016/s0140-6736(19)33004-1
  13. Yadav SK, Bhat AA, Hashem S, et al. Genetic variations influence brain changes in patients with attention-deficit hyperactivity disorder. Translational Psychiatry. 2021;11(1):349. doi: 10.1038/s41398-021-01473-w
  14. Wimberley T, Agerbo E, Horsdal H, et al. Genetic liability to ADHD and substance use disorders in individuals with ADHD. Addiction. 2020;115(7):1368–77. doi: 10.1111/add.14910
  15. Mathews C, Morrell H, Molle J. Video game addiction, ADHD symptomatology, and video game reinforcement. The American Journal of Drug and Alcohol Abuse. 2018;45(1):67–76. doi: 10.1080/00952990.2018.1472269
  16. Menendez-García A, Jiménez-Arroyo A, Rodrigo-Yanguas M, et al. Internet, video game and mobile phone addiction in children and adolescents: a case-control study. Adicciones. 2020;20(10). doi: 10.20882/adicciones.1469
  17. Samela T, Innamorati M, Lester D, et al. The association between adult ADHD and food addiction: A mediation analysis. Appetite. 2021;167:105613. doi: 10.1016/j.appet.2021.105613
  18. Spera V, Pallucchini A, Maiello M, et al. Substance Use Disorder in Adult-Attention Deficit Hyperactive Disorder Patients: Patterns of Use and Related Clinical Features. International Journal of Environmental Research and Public Health. 2020;17(10):3509. doi: 10.3390/ijerph17103509
  19. Soler Artigas M, Sánchez-Mora C, Rovira P, et al. Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Molecular Psychiatry. 2019;25(10):2493–503. doi: 10.1038/s41380-018-0339-3
  20. Young S, Woodhouse E. Assessment and treatment of substance use in adults with ADHD: a psychological approach. Journal of Neural Transmission. 2021;128(7):1099–108. doi: 10.1007/s00702-020-02277-w
  21. Kooij SJJ, Bejerot S, Blackwell A, et al. European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD. BMC Psychiatry. 2010;10:67. doi: 10.1186/1471-244x-10-67
  22. Pozzi M, Bertella S, Gatti E, et al. Emerging drugs for the treatment of attention-deficit hyperactivity disorder (ADHD). Expert Opinion on Emerging Drugs. 2020;25(4):395–407. doi: 10.1080/14728214.2020.1820481
  23. Wong HC, Zaman R. Neurostimulation in Treating ADHD. Psychiatria Danubina. 2019;31(Suppl 3):265–75.
  24. Arns M, Clark CR, Trullinger M, et al. Neurofeedback and Attention-Deficit/Hyperactivity-Disorder (ADHD) in Children: Rating the Evidence and Proposed Guidelines. Applied Psychophysiology and Biofeedback. 2020;45(2):39–48. doi: 10.1007/s10484-020-09455-2
  25. Lim CG, Lim-Ashworth NSJ, Fung DSS. Updates in technology-based interventions for attention deficit hyperactivity disorder. Current Opinion in Psychiatry. 2020;33(6):577–85. doi: 10.1097/YCO.0000000000000643
  26. Gabriely R, Tarrasch R, Velicki M, et al. The influence of mindfulness meditation on inattention and physiological markers of stress on students with learning disabilities and/or attention deficit hyperactivity disorder. Research in Developmental Disability. 2020;100:103630. doi: 10.1016/j.ridd.2020.103630
  27. Chen SC, Yu BY, Suen LK, et al. Massage therapy for the treatment of attention deficit/hyperactivity disorder (ADHD) in children and adolescents: A systematic review and meta-analysis. Complementary Therapies in Medicine. 2019;42:389–99. doi: 10.1016/j.ctim.2018.12.011
  28. Păsărelu CR, Andersson G, Dobrean A. Attention-deficit/ hyperactivity disorder mobile apps: A systematic review. International Journal of Medical Informatics. 2020;138:104133. doi: 10.1016/j.ijmedinf.2020.104133

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2021 ООО "Эко-Вектор"


 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).